Status:
COMPLETED
Oral Sucrose Versus Glucose for Procedural Pain in Premature Neonates
Lead Sponsor:
Loma Linda University
Conditions:
Neonatal Procedural Pain
Eligibility:
All Genders
Up to 7 years
Phase:
NA
Brief Summary
Premature neonates admitted to the neonatal intensive care unit (NICU) require up to several hundred procedures during their hospitalization. Many of these are tissue-damaging procedures (TDPs) that c...
Eligibility Criteria
Inclusion
- Potential subjects are premature infants ≤ 34 weeks gestation and ≤ 7 days of age postnatally
Exclusion
- requirement for surgery
- intraventricular hemorrhage (IVH) ≥ grade 3
- neonates on medications such as morphine, fentanyl, versed, muscle relaxants, phenobarbital, or dilantin,
- renal injury (plasma creatinine \> 1 mg/dl,
- severe cyanotic heart disease or severe respiratory distress,
- known abdominal wall or intestinal anomaly or injury (NEC),
- chromosomal anomaly and (8) facial anomaly
Key Trial Info
Start Date :
February 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT01894659
Start Date
February 1 2014
End Date
July 31 2020
Last Update
September 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Medical Center
Loma Linda, California, United States, 92354